Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2018

2018-03-31
Price :
Published : Mar-2018
No. of Pages : 76
order by fax Inquire before Buying request discount
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Source 76

List of Tables
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2018* 15
Neonatal Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Neonatal Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2018* 18
Neonatal Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Neonatal Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Neonatal Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2018* 15
Neonatal Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Neonatal Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2018* 18
Neonatal Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Neonatal Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Neonatal Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Neonatal Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Neonatal Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 75
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData